Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa

BACKGROUND: Colistin has a narrow therapeutic window with nephrotoxicity being the major dose-limiting adverse effect. Currently, the optimal doses and therapeutic plasma levels are unknown. METHODS: Prospective observational cohort study, including patients infected by colistin-susceptible P. aerug...

詳細記述

保存先:
書誌詳細
出版年:BMC Infect Dis
主要な著者: Sorlí, Luisa, Luque, Sonia, Segura, Concepción, Campillo, Nuria, Montero, Milagro, Esteve, Erika, Herrera, Sabina, Benito, Natividad, Alvarez-Lerma, Francisco, Grau, Santiago, Horcajada, Juan Pablo
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2017
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217330/
https://ncbi.nlm.nih.gov/pubmed/28056821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-016-2117-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料